Arndt Vogel, Head of the Center for Personalized Medicine, MHH at Medical University of Hanover, shared a post on X:
“Hot off the press!
Changing Treatment Landscape of HCC: A RW Analysis of Treatment Algorithms and Outcomes of Patients over 10 Years
less use of TACE, more SIRT and systemic, but overall outcome still poor”
Title: Changing Treatment Landscape of Hepatocellular Carcinoma: A Real‑World Retrospective Analysis of Treatment Algorithmsand Outcomes of Patients over 10 Years
Authors: Melanie Bathon, Nele Binder, Sabrina Welland, Christoph Gerdes, Thomas Wirth, Kristina I. Ringe, Markus Quante, Arndt Vogel, Anna Saborowski.
You can also read ‘FDA Accepts Daraxonrasib NDA for Review in Previously Treated Metastatic Pancreatic Cancer‘
